Corporate Governance31 Jul 2026, 07:10 pm
Glenmark Pharma Authorizes Officials for Disclosure
AI Summary
Glenmark Pharmaceuticals Ltd. has announced amendments to its Policy on Determination of Materiality for Disclosures, approved by the Board of Directors on July 31, 2026. The company has also designated specific officials authorized to determine the materiality of events or information and make necessary disclosures to the stock exchanges as per SEBI regulations. This move ensures compliance and transparency in corporate communication.
Key Highlights
- Board approved amendments to Materiality Determination Policy.
- Designated officials authorized for stock exchange disclosures.
- Ensures compliance with SEBI Listing Obligations and Disclosure Requirements.
- Enhances transparency in corporate event reporting.
Price Impact
More from GLENMARK